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Ovine adenovirus OAV287 (OAV) is phylogenetically and serotypically distinct from human Ad5. OAV grows productively in
CSL503 foetal ovine lung cells and abortively infects several human cell lines. OAV has a unique fiber and a penton protein
that lacks a recognisable integrin-binding motif. It is not known whether a secondary receptor is required for infection. A
hybrid virus was constructed in which the cell binding domain on the OAV fiber protein was exchanged for the equivalent
region from human adenovirus type 5. The hybrid OAV grew to titres that were 1 to 2 log10 lower than wild-type OAV in
permissive ovine cells. Human Ad5 also infected CSL503 cells but failed to compete with OAV for receptor binding sites on
those cells. However, the hybrid virus did compete with Ad5, consistent with its use of the Ad primary receptor. The hybrid
virus was also neutralised by Ad5 antiserum whereas OAV was not. Human 293 kidney and LNCaP prostate cell lines that
were not detectably infected by OAV were infected by the hybrid virus and other human prostate and breast cancer cell lines
showed greatly enhanced infectivity. Thus, modification of the fiber cell binding domain was sufficient to profoundly alter the
tropism of OAV, suggesting that the interaction between the primary receptor and the virus particle is the major factor
controlling virus entry during infection. © 1998 Academic Press
INTRODUCTION
Human adenoviruses infect a wide variety of cell types
by what is generally thought to be a two-step process.
Binding of virus particles to the cell surface usually
occurs by an interaction between the cell binding do-
main (cbd) located at the tip of the trimeric fiber protein
(Philipson et al. 1968; Henry et al., 1994; Xia et al., 1994)
and a primary cellular receptor. After binding, secondary
interactions between an Arg/Gly/Asp (RGD) motif in the
penton base protein and cellular integrins are thought to
enhance internalisation of particles via endocytosis (Bai
et al., 1993; Wickham et al., 1993). However, there are
now numerous variations to this theme. In the context of
hematopoietic cells, interactions between the penton
base protein and distinct integrins alone can mediate
Ad2 binding and entry, b2 integrin acting as the primary
receptor with av integrin mediating uptake (Huang et al.,
1996). Similarly, direct interaction of Ad9 with av integrin
facilitates virus uptake (Roelvink et al., 1996). In other
circumstances where the RGD motif is absent, an inte-
grin-independent pathway that is receptor concentration-
dependent appears to operate. Multiple attachment
points between fiber and a cellular receptor may be
utilised to promote virus uptake (Freimuth, 1996). Thus, in
particular cell types, different proteins can serve as at-
tachment points for adenoviruses that bind via the fiber
or penton protein. The combination of interactions be-
tween viral capsid proteins and the cellular receptors
determines the tropism of the virus. Understanding these
interactions and how they operate for particular viruses
will be important for the design of viral vectors with the
ability to target specific cell types.
In contrast to human Ads, cell binding and uptake of
non-human Ads has not been well studied. No primary
receptor has been identified and because RGD motifs
are altered or missing (Bai et al., 1993; Vrati et al., 1996a),
the involvement of secondary receptors in uptake re-
mains to be determined. Conceivably, other capsid se-
quences could be utilised for secondary interactions or
viruses may enter cells via the primary receptor, as
suggested for RGD-negative human Ads (Freimuth,1996).
We are investigating an ovine adenovirus OAV287 (OAV),
which is the best studied member of a new group of
adenoviruses that are phylogenetically distinct from the
Mastadenoviruses and Aviadenoviruses (Harrach et al.,
1997). OAV grows well in a foetal ovine lung cell line and,
to a limited extent, in bovine nasal turbinate cells (Boyle
et al., 1994; Khatri et al., 1997). The OAV fiber is predicted
to contain 25 repeating units and has a unique C-termi-
nal cbd of 121 residues (Vrati et al., 1995) that is smaller
than the cbd of Ad5 (185 residues), suggesting that OAV
recognises a different receptor. The OAV penton shows
55% identity with Ad2 penton, but the sequences corre-
sponding to the RGD domain are missing (Vrati et al.,
1996a). Despite its distinctive cell attachment proteins,
OAV infected several human cell lines, albeit with differ-
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ing efficiencies. LNCaP prostate cancer and 293 human
embryonic kidney cells were not detectably infected, as
assayed by transgene expression and reverse transcrip-
tion-polymerase chain reaction (RT-PCR) analysis (Khatri
et al., 1997). In an effort to modify the cell tropism of OAV
and to begin to investigate its process of cell entry, we
constructed a hybrid virus in which the OAV cbd on fiber
was replaced by the larger cbd from Ad5 (Henry et al.,
1994). The effect of this change on the growth properties
and host range of OAV were investigated.
RESULTS
CSL503 cells are infected by Ad5
As a prerequisite for rescuing a hybrid OAV carrying
the Ad5 cbd, it was necessary to identify a cell line that
was both permissive for OAV and carried an appropriate
receptor(s) for Ad5. Because CSL503 cells are one of the
few lines that are permissive for OAV (Boyle et al., 1994;
Khatri et al., 1997), the ability of Ad5 to infect those cells
was investigated using an Ad5/RSV/lacZ recombinant.
Cells were infected at an m.o.i. of 20 to 100 plaque
forming units (pfu)/cell and stained for b-galactosidase
expression after 24 h p.i. Over this range of multiplicities
50 to 90% of the cells were infected (Fig. 1).
Construction and characterisation of
hybrid virus OAV206f
Plasmid pOAV206f was constructed and used to res-
cue the corresponding virus (Fig. 2). Transfection of the
plasmid into CSL503 cells produced a cytopathic effect
after 20 days. This was slower than generally observed
for other rescued viruses (Vrati et al., 1996b; Khatri et al.,
1997; Xu et al., 1997). Digestion of the viral genome with
CelII produced the expected fragments of 26 and 5.6 kb
while digestion with NcoI produced fragments of 9.1, 6.3,
5.5, 3.3, 2.3, 2.0, 1.4, and 1.3 kb (fragments of 0.34 and
0.06 kb were not visible), as predicted from the sequence
(data not shown).
Infectious stocks of OAV206f were grown by infecting
CSL503 cells and allowing cpe to progress to comple-
tion. When CSL503 cells were infected at 1 pfu/cell with
OAV, OAV206, or OAV206f, complete cpe developed in
about 4 days for the first two viruses but took about 6
days for the hybrid virus. Under these conditions the
hybrid virus grew to a titer which was one to two log10
FIG. 2. Construction of an OAV/Ad5 hybrid virus by exchange of cell
binding domains. The hybrid fiber protein contains repeats 21 and 22
plus the cbd of Ad5 fused to repeat 24 of OAV fiber. OAV sequences are
shown in bold.
FIG. 1. Ovine foetal lung fibroblasts are infected by a human Ad5 recombinant. CSL503 cells were infected with 0, 20, or 100 pfu/cell of Ad5/RSV/lacZ
and stained for b-galactosidase expression at 24 h p.i.
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units lower than obtained for other recombinant viruses.
Titres in the range of 5 3 107–1 3 108 pfu/ml were
obtained.
Neutralisation of OAV, Ad5, and OAV206f
A comparison of the capsid protein sequences of Ad5
and OAV predicted that the two viruses should be sero-
typically distinct (Vrati et al., 1996a) but Ad5 antiserum
was expected to neutralise OAV206f because it carries
the Ad5 cbd. To confirm this, duplicate aliquots contain-
ing 50 pfu of OAV, Ad5, or OAV206f were incubated at
room temperature for 1.5 h with serial twofold dilutions of
polyclonal OAV or Ad5 antisera. CSL503 cells were then
infected with pre-incubated OAV or hybrid virus while 293
cells were infected with pre-incubated Ad5. Cells were
incubated for 7 to 14 days to allow a complete cpe to
develop. The data (Table 1) show that none of the viruses
was neutralised by serum from uninfected sheep. OAV
and Ad5 were each neutralised by the homologous se-
rum to a dilution of 2560, but neither virus was neu-
tralised by the reciprocal antiserum even at a dilution of
1:40. This confirmed that OAV is serotypically distinct
from at least one common human adenovirus. OAV206f
and wild-type OAV were neutralised by the OAV anti-
serum at the same dilution because the two viruses had
common hexon and penton proteins that are major viral
antigens. However, OAV206f was also neutralised by the
Ad5 antiserum, albeit at a slightly lower dilution than Ad5
(Table 1), confirming that it carried the Ad5 cbd.
OAV206f infects CSL503 cells via an Ad5 receptor
Competitive binding experiments were carried out to
investigate whether OAV and Ad5 bind to cells via dis-
tinct receptors. To allow binding but to prevent uptake
CSL503 cells were incubated at 4°C. Radiolabelled Ad5
was incubated with cells in the presence of increasing
amounts of unlabelled Ad5, or OAV216, a recombinant
virus that carried an HCMV/alkaline phosphatase re-
porter cassette (Khatri et al., 1997) but that had an un-
modified fiber protein. Binding of radiolabelled Ad5 was
reduced by competition with unlabelled Ad5 but no sig-
nificant competition was observed with OAV216 (Fig. 3A),
showing that these viruses recognised distinct primary
receptors.
Similarly, binding of radiolabelled OAV206f to CSL503
cells was monitored in the presence of increasing
amounts of OAV216, Ad5, or homologous virus. Compe-
tition with OAV206f was observed, as expected, with a
;50% reduction in binding observed at an input of 100
pfu/cell. However, at this input there was no reduction
with OAV216 (P , 0.05) (Fig. 3B). At an input of 1000
pfu/cell OAV206f homologous competition reduced bind-
ing by ;70%, however, OAV216 produced a reduction of
only ;25% (P , 0.05) (Fig. 3B). At both viral inputs, Ad5
competed equally well with OAV206f. This confirmed that
Ad5 and OAV206f shared a receptor that was distinct
from the receptor for wild-type OAV.
Altered cell tropism of OAV206f
The ability of OAV206f to infect various cell types was
compared with that of the parental OAV206 (which car-
ried the identical gene cassette) using equal inputs of
virus for infection. Virus preparations were titred by
FIG. 3. Competitive binding of viruses to CSL503 cells. Radiolabelled
Ad5 (A) or OAV206f (B) was bound to CSL503 cells at 4°C in the
presence of increasing amounts of unlabelled Ad5, OAV206f, or
OAV216, as indicated. OAV216 carries a wild-type fiber cbd. Data points
represent the means of duplicate samples. Standard t tests were used
to analyse the statistical significance of the data (see text).
TABLE 1




Ad5 ,1:40 1:2560 1:1280
OAV 1:2560 ,1:40 1:2560
Normal
ovine ,1:20 ,1:20 ,1:20
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plaque assay, and an equal number of pfus were anal-
ysed by SDS-PAGE to determine viral particle levels.
Although not pure, it was apparent that each virus prep-
aration contained a similar number of particles based on
the relative amounts of structural proteins, e.g., hexon
and pVII, that were resolved (Fig. 4, lanes 1 and 2).
Permissive CSL503 cells were then infected with OAV206
or OAV206f at an m.o.i. of 10 pfu/cell. Expression of
VP7sc was monitored by radioimmuno-precipitation at
12, 24, and 36 h p.i. The kinetics and level of expression
of the reporter by the two viruses was essentially iden-
tical over this time frame (Fig. 5A, lanes 3, 4, 6, and 7).
Approximately equal numbers of nonpermissive cells
were then infected with the two viruses at an m.o.i. of 10
pfu/cell. Although OAV206 is known to infect and express
VP7sc in several of the cell types used below (Khatri et
al., 1997), under the conditions of analysis used in these
experiments VP7sc expression was not detectable at 12
to 36 h p.i. in OAV206-infected MCF-7 cells (Fig. 5A, lanes
9 to 11) or at 12 to 48 h p.i. in LNCaP (Fig. 5B, lanes 2 to
4), PC-3 (Fig. 5B, lanes 9 to 11), or 293 cells (Fig. 5C,
lanes 2 to 4). However, after infection with OAV206f,
VP7sc was prominently expressed in MCF-7, LNCaP, and
FIG. 4. OAV206 and OAV206f preparations contain similar particle
numbers. An equal number of pfu of OAV206f (lane 1) and OAV206 (lane
2) were analysed by SDS-PAGE together with a purified, unrelated OAV
recombinant (lane 3). The positions of previously described hexon and
VII proteins (Vrati et al., 1996a) on the silver stained gel are indicated.
FIG. 5. VP7sc expression in various human cell types is greatly increased by infection with OAV206f. Cells were left uninfected (U) or were infected
with OAV206 or OAV206f at an m.o.i. of 10 pfu/cell, radiolabelled and harvested at 12 to 48 h p.i., as indicated. VP7sc was recovered by
immunoprecipitation and analysed by SDS-PAGE. (M) Lanes contain marker proteins of the sizes indicated.
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PC-3 cells (Figs. 5A, lanes 12 to 14, and 5B, lanes 5 to 7
and 12 to 14) and detectably expressed in 293 cells (Fig.
5C, lanes 5 to 7).
The above results for LNCaP cells were confirmed by
immuno-fluorescence studies, which also indicated the
number of cells that were infected. LNCaP cells infected
at an m.o.i. of 10 with the control virus OAV206 showed
no significant immunofluorescence, as expected from
the above results (Fig. 6, top). However, with OAV206f an
increasing number of cells expressed VP7sc after infec-
tion at m.o.i.s of 0.1, 1, and 10 (Fig. 6, left). Infectivity by the
hybrid virus compared favourably with that of the Ad5
FIG. 6. Expression of VP7sc in OAV206f-infected LNCaP prostate cancer cells. Cells were infected at with OAV206 at an m.o.i. of 10 or with OAV206f
or AdCMV7R at m.o.i.s of 0.1, 1, and 10. VP7sc expression was monitored by immunofluorescence at 72 h p.i. The top panel represents a negative
control because OAV206 does not infect LNCaP cells.
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recombinant, AdCMV7R (Xu et al., 1995), which showed
similar infectivity in LNCaP cells (Fig. 6, right). Thus,
changing the cbd of OAV dramatically improved its ability
to infect several nonpermissive cell types and increased
its ability to infect a previously recalcitrant cell line to a
level comparable with an Ad5 vector.
DISCUSSION
There is considerable interest in modifying Ad cell
binding capabilities to develop new vectors that could be
targeted to specific cell types. Ads bind to cellular re-
ceptors via a binding domain formed by C-terminal se-
quences of the fiber protein (Philipson et al., 1968; Henry
et al., 1994; Xia, et al., 1994). Because some receptors are
distinct, exchanging appropriate cbds while maintaining
the ability of fiber to fold and trimerise should therefore
modify viral tropism. Viruses in which the cbd of Ad5 was
exchanged for the cbd of Ad7A (Gall et al., 1996) or Ad3
(Stevenson et al., 1995, 1997) have been constructed, and
in the latter case, altered cell tropism was demonstrated.
In both cases, the size of the substituted cbd was very
similar to the cbd that replaced it and little or no differ-
ence in the growth properties of the hybrid viruses was
noted (Gall et al., 1996; Stevenson et al., 1997).
The present work necessitated a more dramatic mod-
ification of the fiber protein because the OAV cbd, which
is thought to be ;121 amino acids in size (Vrati et al.,
1995), was replaced by the Ad5 cbd comprising ;185
residues. Following transfection of its plasmid (Vrati et
al., 1996b), OAV206f was rescued, although cpe ap-
peared more slowly in CSL503 cells than when other
viruses were rescued (Khatri et al., 1997; Xu et al., 1997).
The growth of OAV206f was also significantly impaired
compared with OAV206. The reason(s) for this is not
clear but may relate to an impaired rate of virus assem-
bly or exit, rather than entry, because the early kinetics of
expression of the transgene in synchronous infections by
OAV206f and OAV206 were very similar (Fig. 5A). Several
attempts to rescue a second fiber-modified virus carrying
an alkaline phosphatase reporter gene cassette have
been unsuccessful under conditions where the rescue of
other viruses has succeeded (unpublished observa-
tions). Perhaps, because of size difference, the exchange
of cbds in this work might be close to the tolerable limit.
Further work is required to test this.
Competitive binding experiments with OAV206 and
OAV206f were carried out to investigate early events in
virus binding and uptake by CSL503 cells. A constant
amount of radiolabelled OAV206f was competed with
increasing amounts of unlabelled OAV206. Preparations
of these viruses contained similar numbers of particles
as determined by SDS polyacrylamide gel analysis (Fig.
4), but OAV206 competed inefficiently with OAV206f, dem-
onstrating that these two viruses carried distinct cbds.
The particle to pfu ratio of the Ad5 virus preparation was
not determined, however, Ad5 competed efficiently with
OAV206f, consistent with the fact that at the genetic level
the viruses were designed with a common cbd.
OAV penton lacks an RGD domain (Vrati et al., 1996a),
and it is not known whether a secondary receptor is
involved in OAV uptake. Nevertheless, we also attempted
to rescue a hybrid OAV in which RGD sequences
(102 amino acids) from the Ad5 penton were inserted
at residue 247 of OAV penton i.e., LTKGNISPLL-
DVDAYQSLK. . .43aas. . . RGD. . .39aas. . . KPQKKPVL-
EPVM QDEN GVSYNEKIS (OAV sequences are shown in
bold). However, rescue of this virus was also unsuccess-
ful. A smaller insertion, e.g., the equivalent sequences
from Ad12, may have been more appropriate but has not
been attempted because it seems that the primary re-
ceptor is more important for OAV uptake, as discussed
below. Other integrin-binding motifs that have been de-
scribed for cell adhesion proteins (Hynes, 1992) are also
absent from OAV structural polypeptides, with the excep-
tion of DGEH, a sequence that is closely related to
DGE(A), which binds a1b1 integrin (Hynes, 1992). DGEH
is present within p28K, an OAV structural protein whose
position in the viral capsid is unknown (Vrati et al.,1996a).
The significance of this observation being uncertain, it
seems likely that OAV may enter cells via a single recep-
tor, unless other undefined viral sequences bind integrin
or another cellular protein.
Recently two primary receptors for Ad5 were identified
on HeLa cells. CAR, a protein that acts as a receptor for
coxsackie B viruses and adenovirus types 2 and 5 (Ad2,
Ad5) was described (Bergelson et al., 1997; Tomko et al.,
1997), and an alternative binding site for Ad5 was also
identified on the conserved a2-domain of MHC-I com-
plexes (Hong et al., 1997). Competitive binding experi-
ments carried out in this work confirmed that the OAV
and Ad5 receptors on CSL503 cells are distinct. Although
it is unknown whether OAV requires a secondary recep-
tor for infection, our data suggest that the interaction
between the primary receptor and the virus particle is the
major factor controlling virus entry during infection. In the
absence of other changes, the inability of OAV to infect
293 and LNCaP cells was overcome simply by substitut-
ing the Ad5 cbd, and, in addition, MCF-7 and PC-3 cells
were more efficiently infected by the hybrid virus than by
OAV206. (Because OAV206 and OAV206f carried the
identical promoter/gene cassette, the data for a given
cell type cannot be explained by transcriptional or trans-
lational differences). The simplest interpretation of these
results is that OAV206f infected 293 and LNCaP cells
because the Ad5 receptor was present (both lines were
infected by Ad5) while the OAV receptor was not,
whereas for PC-3 and MCF-7 cells the Ad5 receptor was
present in greater numbers. The reduced ability of
OAV206f to infect 293 compared with LNCaP cells may
also reflect a difference in Ad5 receptor numbers be-
tween these cell types. Alternatively, efficient infection of
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293, but not LNCaP cells (and other cell types) may
require interaction with a secondary receptor such as
integrin, as typified by Ad5 (Wickham et al., 1993). OAV
lacks such an integrin-binding domain (Vrati et al.,
1996a).
Infection of human cells by OAV206 and OAV206f mim-
ics the situation described for infection of A549 cells by
Ad2 mutants which lack the penton RGD motif (Freimuth,
1996). In this case, it was demonstrated that virus inter-
nalisation was receptor concentration dependent, entry
being facilitated by recruitment of multiple receptors. It
now seems possible, given the emerging diversity of
receptors (Bergelson et al., 1997; Hong et al., 1997;
Tomko et al., 1997), that the virus could bind one or more
fiber protein receptors on the cell surface. As long as one
protein was recycled to the endosomes by endocytosis,
the virus would achieve entry. In addition, no particular
spatial arrangement between primary and secondary
receptors is required. It was recently demonstrated that
infection by fiber antibody-adapted Ads could occur via
nonadenovirus receptors and that the binding and sub-
sequent entry steps were not linked (Douglas et al., 1996;
Wickham et al., 1996). Similar adaptation of OAV should
produce a targeted virus that would retain its abortive
replication properties in the cell (Khatri et al., 1997).
However, the efficiency and kinetics of uptake via a
single receptor need to be considered.
MATERIALS AND METHODS
Viruses and antisera
Human adenovirus type 5 (Ad5) was obtained from
ATCC. An Ad5/RSV/lacZ recombinant that expressed
b-galactosidase from the Rous Sarcoma Virus (RSV) pro-
moter was obtained from Dr. M. Perricaudet (Inst
Gustave Roussy, CNRS, France). AdCMV7R, an Ad5 re-
combinant that carried a reporter gene cassette (HCMV/
VP7sc) in which the rotavirus VP7sc gene was expressed
from the human cytomegalovirus (HCMV) promoter, was
constructed previously (Xu et al., 1995). The origin of
OAV287 (OAV) has been described (Boyle et al., 1994).
OAV206 and OAV216 are recombinant ovine adenovi-
ruses that express VP7sc or human placental alkaline
phosphatase, respectively, from the HCMV promoter
(Khatri et al., 1997), but are otherwise identical and have
a wild-type fiber protein. Polyclonal antiserum to Ad5
was purchased from ATCC. Polyclonal antiserum against
OAV was raised in sheep as previously described (Boyle
et al., 1994).
Cell lines
The following cell lines were used in this work:
CSL503, embryonic ovine lung fibroblast; and human
lines, 293 embryonic kidney; LNCaP, prostate cancer;
PC-3, prostate cancer and MCF-7, breast cancer. Their
source and culture conditions were described previously
(Khatri et al., 1997).
Construction of an OAV/Ad5 hybrid virus
Strategies for the construction of OAV recombinant plas-
mids and the rescue of infectious viruses have been de-
scribed previously (Vrati et al., 1996b). Plasmid pOAV206
contains a reporter gene cassette, HCMV/VP7sc, inserted
at site I in the intergenic region between the pVIII and fiber
genes. This plasmid was further modified to replace the
sequences encoding shaft repeat units 24 and 25 (the last
two repeats) plus the cbd of the OAV fiber protein with the
equivalent sequences from human Ad5 (Henry et al., 1994).
An ;7.2-kb SphI/SalI fragment of OAV that contained the
fiber gene and adjacent sequences was subcloned into
SphI/SalI-cut plasmid pAlter-1 (Promega, Madison, WI). Mu-
tagenic oligonucleotides and the Altered Sites II mutagen-
esis kit (Promega) were used to introduce unique restriction
sites at the appropriate locations in the fiber gene. The
introduction of an NcoI site in repeat 24 of OAV fiber (Vrati
et al., 1995) altered the amino acid sequence from NALTLN
to NAMVLN. The C-terminal sequence AHQFRQ was
changed to AHQARQ by introducing a CelII site. Oligonu-
cleotide primers incorporating NcoI and CelII sites were
used to PCR-amplify the equivalent portion of fiber in the
Ad5 genome from the MVPKLG sequence in repeat 21 to
the C terminus. This PCR fragment was digested with NcoI
and CelII and cloned into the NcoI/CelII-cut recombinant
pAlter-1 plasmid to replace the OAV sequences. A ;6.2-kb
AgeI/SalI fragment containing the hybrid fiber gene was
then subcloned into AgeI/SalI-cut plasmid pOAV206 to cre-
ate pOAV206f. The sequence of the relevant parts of the
hybrid fiber protein is shown in Fig. 2.
Virus rescue, preparation, and titration
Plasmid pOAV206f was digested with KpnI to re-
lease the linear viral genome and transfected into
CSL503 cells using lipofectamine (GibcoBRL) as de-
scribed previously (Vrati et al., 1996b). A cytopathic
effect appeared in one of eight 60-mm dishes of cells
after 3 weeks. The virus rescued was grown and
characterised by restriction enzyme digestion to con-
firm that its genome structure was correct. Virus
stocks were grown in CSL503 cells.
Ad5 and OAV206f viruses were grown in 293 or
CSL503 cells, respectively. To prepare radiolabelled vi-
ruses, cells at ;80% confluency in a 100-mm dish were
infected at an m.o.i. of 5 pfu/cell. After 16 to 24 h, cells
were incubated in 5 ml of serum-free medium containing
0.2 mCi of 3[H]-thymidine (ICN, Irvine, CA). After 8 h, 8 ml
of medium was added. Cells were harvested at 48 to 80 h
p.i. in 0.1 M Tris.HCl, pH 8.0. Virus was released by three
freeze/thaw cycles and purified by CsCl gradient centrif-
ugation as previously described (Boyle et al., 1994).
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Virus binding assays
Binding of viruses to CSL503 or 293 cells was carried out
as follows. Approximately 5 3 104 cells/well were grown in
a 96-well tissue culture plate. Cells were washed once with
binding medium (MEM supplemented with 20 mM HEPES
and 2 mM MgCl2). Duplicate wells were pre-incubated in
binding medium with increasing amounts of unlabelled
virus for 2 h at 4°C. A fixed amount of 3[H]-labeled virus was
added and the cells were incubated for 1 h at 4°C. The
inoculum was then removed and the cells were washed
three times with PBS containing 0.2% Triton-X100. Cells
were solubilised and radioactivity was determined by liquid
scintillation counting.
Infection of cells and expression of antigens
CSL503 and human cell lines were mock infected or
infected with viruses at multiplicities of infection of 0.1 to
20 pfu/cell as described previously (Xu et al., 1995).
Infection was allowed to proceed for 24 to 72 h. Cells
were then incubated in methionine-free medium in the
presence of [35S]methionine to label newly synthesized
proteins. VP7sc was recovered from cell lysates by im-
munoprecipitation using a rotavirus antiserum (Xu et al.,
1995). Proteins were analysed by polyacrylamide gel
electrophoresis and detected by autoradiography or by
using a phosphorimager (Molecular Dynamics). Alterna-
tively, VP7sc expression was monitored by immunofluo-
rescence as described previously (Khatri et al., 1997)
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